Linda Steinbichl

Linda Steinbichl

Auto-generated profile, based on publicly available information

Linda Steinbichl

Center of Anatomy and Cell Biology, Division of Cell and Developmental Biology, Medical University of Vienna 1 , Vienna

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2025 in Journal of Experimental Medicine
Verified
Journal Article
Open access
RGRiem Gawish
Riem Gawish
RVRajagopal Varada
Rajagopal Varada
FDFlorian Deckert
Florian Deckert
AHAnastasiya Hladik
Anastasiya Hladik
LSLinda Steinbichl
Linda Steinbichl
CVCornelia Vesely
Cornelia Vesely
Patho-mechanistic origins of ulcerative colitis are still poorly understood. The actin cross-linker filamin A (FLNA) impacts cellular responses through interaction with cytosolic proteins. Posttranscriptional A-to-I editing generates two forms of FLNA: genome-encoded FLNAQ and FLNAR. FLNA is edited in colon fibroblasts, smooth muscle cells, and endothelial cells. We found that the FLNA editing status determines colitis severity. Editing was highest in healthy colons and reduced during murine and human colitis. Mice that exclusively express FLNAR were highly resistant to DSS-induced colitis, whereas fully FLNAQ animals developed severe inflammation. While the genetic induction of FLNA editing influenced transcriptional states of structural cells and microbiome composition, we found that FLNAR exerts protection specifically via myeloid cells, which are physiologically unedited. Introducing fixed FLNAR did not hamper cell migration but reduced macrophage inflammation and rendered neutrophils less prone to NETosis. Thus, loss of FLNA editing correlates with colitis severity, and targeted editing of myeloid cells serves as a novel therapeutic approach in intestinal inflammation.